BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16707604)

  • 1. Prognostic significance of activated AKT expression in soft-tissue sarcoma.
    Tomita Y; Morooka T; Hoshida Y; Zhang B; Qiu Y; Nakamichi I; Hamada K; Ueda T; Naka N; Kudawara I; Aozasa K
    Clin Cancer Res; 2006 May; 12(10):3070-7. PubMed ID: 16707604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of activated Akt expression in pancreatic ductal adenocarcinoma.
    Yamamoto S; Tomita Y; Hoshida Y; Morooka T; Nagano H; Dono K; Umeshita K; Sakon M; Ishikawa O; Ohigashi H; Nakamori S; Monden M; Aozasa K
    Clin Cancer Res; 2004 Apr; 10(8):2846-50. PubMed ID: 15102693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of phosphorylated FOXO1 expression in soft tissue sarcoma.
    Zhang B; Tomita Y; Ch'ng E; Qiu Y; He J; Jin YF; Tomoeda M; Hamada K; Ueda T; Aozasa K
    Ann Surg Oncol; 2009 Jul; 16(7):1925-37. PubMed ID: 19408047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forkhead protein FKHR and its phosphorylated form p-FKHR in human prostate cancer.
    Li R; Erdamar S; Dai H; Wheeler TM; Frolov A; Scardino PT; Thompson TC; Ayala GE
    Hum Pathol; 2007 Oct; 38(10):1501-7. PubMed ID: 17597184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of CD100 expression in soft tissue sarcoma.
    Ch'ng E; Tomita Y; Zhang B; He J; Hoshida Y; Qiu Y; Morii E; Nakamichi I; Hamada K; Ueda T; Aozasa K
    Cancer; 2007 Jul; 110(1):164-72. PubMed ID: 17520683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTEN-positive and phosphorylated-Akt-negative expression is a predictor of survival for patients with advanced endometrial carcinoma.
    Uegaki K; Kanamori Y; Kigawa J; Kawaguchi W; Kaneko R; Naniwa J; Takahashi M; Shimada M; Oishi T; Itamochi H; Terakawa N
    Oncol Rep; 2005 Aug; 14(2):389-92. PubMed ID: 16012720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Akt and phosphorylated Akt expression are associated with malignant biological features of prostate cancer in Japanese men.
    Shimizu Y; Segawa T; Inoue T; Shiraishi T; Yoshida T; Toda Y; Yamada T; Kinukawa N; Terada N; Kobayashi T; Kinoshita H; Kamoto T; Nakamura E; Ogawa O
    BJU Int; 2007 Sep; 100(3):685-90. PubMed ID: 17542985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Akt/mammalian target of rapamycin pathway is activated and associated with adverse prognosis in soft tissue leiomyosarcomas.
    Setsu N; Yamamoto H; Kohashi K; Endo M; Matsuda S; Yokoyama R; Nishiyama K; Iwamoto Y; Dobashi Y; Oda Y
    Cancer; 2012 Mar; 118(6):1637-48. PubMed ID: 21837670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive immunohistochemical approach of AKT/mTOR pathway and p-STAT3 in mycosis fungoides.
    Levidou G; Siakantaris M; Papadaki T; Papadavid E; Vassilakopoulos TP; Angelopoulou MK; Marinos L; Nikolaou V; Economidi A; Antoniou C; Patsouris E; Korkolopoulou P
    J Am Acad Dermatol; 2013 Sep; 69(3):375-84. PubMed ID: 23685026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers.
    Hommura F; Dosaka-Akita H; Mishina T; Nishi M; Kojima T; Hiroumi H; Ogura S; Shimizu M; Katoh H; Kawakami Y
    Clin Cancer Res; 2000 Oct; 6(10):4073-81. PubMed ID: 11051259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffuse myogenin expression by immunohistochemistry is an independent marker of poor survival in pediatric rhabdomyosarcoma: a tissue microarray study of 71 primary tumors including correlation with molecular phenotype.
    Heerema-McKenney A; Wijnaendts LC; Pulliam JF; Lopez-Terrada D; McKenney JK; Zhu S; Montgomery K; Mitchell J; Marinelli RJ; Hart AA; van de Rijn M; Linn SC
    Am J Surg Pathol; 2008 Oct; 32(10):1513-22. PubMed ID: 18708938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal ischemia/reperfusion and ATP depletion/repletion in LLC-PK(1) cells result in phosphorylation of FKHR and FKHRL1.
    Andreucci M; Michael A; Kramers C; Park KM; Chen A; Matthaeus T; Alessandrini A; Haq S; Force T; Bonventre JV
    Kidney Int; 2003 Oct; 64(4):1189-98. PubMed ID: 12969136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of phospho-Akt correlates with phosphorylation of EGF receptor, FKHR and BAD in nasopharyngeal carcinoma.
    Yip WK; Leong VC; Abdullah MA; Yusoff S; Seow HF
    Oncol Rep; 2008 Feb; 19(2):319-28. PubMed ID: 18202777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation and nuclear exclusion of the forkhead transcription factor FKHR after epidermal growth factor treatment in human breast cancer cells.
    Jackson JG; Kreisberg JI; Koterba AP; Yee D; Brattain MG
    Oncogene; 2000 Sep; 19(40):4574-81. PubMed ID: 11030146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the Akt-mTOR pathway and receptor tyrosine kinase in patients with solitary fibrous tumors.
    Yamada Y; Kohashi K; Fushimi F; Takahashi Y; Setsu N; Endo M; Yamamoto H; Tokunaga S; Iwamoto Y; Oda Y
    Cancer; 2014 Mar; 120(6):864-76. PubMed ID: 24353015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective usage of D-Type cyclins by Ewing's tumors and rhabdomyosarcomas.
    Zhang J; Hu S; Schofield DE; Sorensen PH; Triche TJ
    Cancer Res; 2004 Sep; 64(17):6026-34. PubMed ID: 15342383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancer.
    Malik SN; Brattain M; Ghosh PM; Troyer DA; Prihoda T; Bedolla R; Kreisberg JI
    Clin Cancer Res; 2002 Apr; 8(4):1168-71. PubMed ID: 11948129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
    Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
    BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylated 4E-binding protein 1 (p-4E-BP1): a novel prognostic marker in human astrocytomas.
    Korkolopoulou P; Levidou G; El-Habr EA; Piperi C; Adamopoulos C; Samaras V; Boviatsis E; Thymara I; Trigka EA; Sakellariou S; Kavantzas N; Patsouris E; Saetta AA
    Histopathology; 2012 Aug; 61(2):293-305. PubMed ID: 22690797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive correlation between overexpression of phospho-BAD with phosphorylated Akt at serine 473 but not threonine 308 in colorectal carcinoma.
    Khor TO; Gul YA; Ithnin H; Seow HF
    Cancer Lett; 2004 Jul; 210(2):139-50. PubMed ID: 15183529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.